Testosterone Therapy For Women: Addressing Systemic Health Beyond Libido

The Unseen Hormone: Why Testosterone Matters for Women and the Systemic Consequences of Its Neglect

This conversation with Shalin Shah, CEO of Merys Pharmaceuticals, reveals a critical blind spot in women's health: the pervasive underestimation and mistreatment of testosterone's role. While men have a well-established pathway for testosterone therapy, women are often left to navigate a landscape of myths and limited options, leading to significant downstream effects on their energy, cognition, metabolism, and relationships. This analysis is crucial for women experiencing midlife health shifts and for healthcare providers seeking to offer comprehensive, evidence-based care. Understanding the systemic neglect of female testosterone needs offers a distinct advantage in advocating for personalized health solutions and achieving true hormonal balance.

The Hidden Cascade: From Brain Fog to Relationship Strain

The conversation with Shalin Shah illuminates a stark disparity in how male and female hormonal health is approached, with profound, often unseen, consequences for women. While testosterone is a critical hormone for both sexes, influencing everything from cellular function and cognitive health to muscle mass and libido, its role in women is frequently dismissed or misunderstood. This dismissal, rooted in historical biases and a lack of approved therapeutic options, creates a systemic deficit that impacts women's well-being across multiple domains. The immediate, visible symptoms--brain fog, declining strength, stubborn weight gain, and sleep disturbances--are often misattributed to "aging" or treated with inadequate solutions like SSRIs, failing to address the underlying hormonal imbalance.

Shah emphasizes that testosterone receptors exist on virtually every organ in the body, underscoring its systemic influence. This broad impact is mirrored in both men and women, yet clinical focus remains heavily skewed. For men, testosterone therapy is relatively established, addressing issues like energy levels, muscle mass, and sexual function. However, for women, the landscape is far more challenging. As of the recording, North America lacks approved testosterone products for women, forcing reliance on off-label use, often solely for hyposexual desire disorder. This narrow indication ignores the hormone's broader physiological roles, leading to a significant mismatch, particularly within heterosexual couples. When one partner experiences declining testosterone and the other does not, it can exacerbate existing intimacy issues and contribute to midlife relationship strain. The anecdote of a divorce lawyer suggesting her caseload would decrease with better access to female hormone therapy highlights the societal cost of this neglect.

"The easy, easy place to start is on the male side because you know folks barely even consider it a female hormone today even though it absolutely is right testosterone is a male and female hormone just like estrogen is a female and male hormone same thing."

-- Shalin Shah

The systemic consequences extend to the very definition of "normal." Shah points out that reference ranges for testosterone, even in men, have steadily declined over decades, meaning that levels once considered low are now deemed "normal." This shift, coupled with a lack of comprehensive diagnostic testing for women, means many individuals may be experiencing suboptimal testosterone levels without even realizing it. The reliance on symptomology alone, while sometimes necessary due to limited approved treatments, can obscure the underlying hormonal picture. The conversation also touches on the environmental and lifestyle factors contributing to declining testosterone levels across the board, including sedentary lifestyles, obesity, microplastics, and disrupted sleep patterns due to screen time. These factors create a complex interplay where hormonal decline can be both a cause and an effect, trapping individuals in a cycle of low energy and poor health.

"The pattern repeats everywhere Chen looked: distributed architectures create more work than teams expect. And it's not linear--every new service makes every other service harder to understand. Debugging that worked fine in a monolith now requires tracing requests across seven services, each with its own logs, metrics, and failure modes."

-- Shalin Shah

The failure to address testosterone in women is not merely a clinical oversight; it's a systemic issue with far-reaching implications for individual health, relationships, and societal well-being. This analysis suggests that a more holistic, hormone-inclusive approach to women's health, supported by better diagnostics and approved therapeutic options, is not just beneficial but essential.

The Unseen Drivers of Decline: Beyond the Obvious Symptoms

The Narrow Lens of Diagnosis: When "Normal" Becomes a Barrier

A critical insight emerging from this discussion is how the very definition of "normal" testosterone levels has shifted, creating a significant barrier to care, particularly for women. Shah explains that reference ranges, even for men, have steadily decreased over decades. What was once considered a healthy level might now fall below the "normal" threshold, leaving individuals with suboptimal hormone function without recourse. This is compounded by the fact that standard blood panels often omit testosterone testing, making it an uphill battle for patients to even initiate the conversation. For women, this diagnostic gap is even more pronounced, as approved treatments are scarce, and the primary indication for off-label use--hyposexual desire disorder--is a narrow and often insufficient lens through which to view testosterone's systemic impact. The implication is that many women are experiencing debilitating symptoms like brain fog, fatigue, and metabolic changes not because they are simply "aging," but because their testosterone levels are suboptimal, a fact that current diagnostic and treatment paradigms fail to capture.

"The pattern repeats everywhere Chen looked: distributed architectures create more work than teams expect. And it's not linear--every new service makes every other service harder to understand. Debugging that worked fine in a monolith now requires tracing requests across seven services, each with its own logs, metrics, and failure modes."

-- Shalin Shah

The Couple's Conundrum: When Hormonal Mismatches Undermine Relationships

The conversation powerfully illustrates the downstream effects of neglecting female testosterone on relationships, particularly within heterosexual couples. Shah highlights a scenario where a man on testosterone replacement therapy (TRT) is addressing his hormonal needs, while his partner experiences declining testosterone and other reproductive hormones. This creates a significant mismatch in libido and energy levels, a "train wreck" that can exacerbate intimacy issues. The current system, by offering a broad suite of options for men and virtually none for women (beyond the narrow HSDD indication), inadvertently widens this gap. This systemic failure not only impacts individual health but also contributes to midlife relationship strain, as evidenced by the divorce lawyer's observation. The argument is that treating hormonal health should consider the couple as a unit, recognizing that imbalances in one partner can significantly affect the dynamics of the relationship. The lack of accessible and comprehensive hormonal support for women means they are often left behind, contributing to a broader societal issue of midlife relationship dissolution.

The Myth of Safety: Cardiovascular Risks and the Delayed Reckoning

A significant portion of the discussion is dedicated to debunking persistent myths surrounding testosterone therapy, particularly concerning cardiovascular risk and prostate cancer. Shah references the TRAVERSE trial, a large, randomized, placebo-controlled study that concluded testosterone therapy does not increase cardiovascular events and may even reduce them. Despite this robust evidence, the myth of cardiovascular risk continues to be a major deterrent, stemming from outdated labeling changes around 2013-2014. Similarly, the notion that testosterone causes prostate cancer in men is debunked as originating from a flawed 1940s study. The reality, as Shah explains, is that testosterone therapy may actually help expose underlying prostate issues rather than cause them. This highlights a broader issue: the slow pace at which medical guidelines and clinical practice adopt new evidence. The Women's Health Initiative (WHI) study, which led to the denial of hormone therapy for women for years, is cited as another example of how flawed research can have decades-long detrimental impacts. This delay in updating medical understanding creates a significant disadvantage for patients, who continue to suffer from conditions that could be effectively managed with current, evidence-based treatments.

Actionable Steps for Hormonal Empowerment

• Prioritize Comprehensive Diagnostics: Advocate for baseline testing of total testosterone, free testosterone, and SHBG, even if your physician doesn't routinely offer it. If possible, establish these baselines in your 20s to track changes over time.
• Educate Your Provider: Arm yourself with information from studies like the TRAVERSE trial to discuss cardiovascular safety and debunk myths about testosterone therapy with your primary care physician. Frame discussions around symptomology and the systemic benefits of testosterone beyond libido.
• Consider the Couple's Health: If you are in a relationship, encourage open conversations about hormonal health with your partner. Advocate for both individuals to have their hormonal profiles assessed and addressed, recognizing the impact on intimacy and overall relationship well-being.
• Explore Off-Label Options Cautiously: If approved options are unavailable, discuss the risks and benefits of off-label testosterone therapy with a knowledgeable provider. Prioritize providers who focus on physiologic dosing and symptom-based adjustments rather than solely relying on broad reference ranges.
• Demand Better for Women: Support pharmaceutical companies and research initiatives focused on developing female-specific testosterone therapies. Stay informed about clinical trial timelines and advocate for greater investment in women's hormonal health research.
• Integrate Lifestyle and Hormonal Support: Recognize that hormonal optimization works synergistically with foundational health practices. While lifestyle changes are crucial, don't hesitate to use tools like testosterone therapy to overcome inertia and support energy levels needed for diet, exercise, and stress management.
• Be Patient with Systemic Change: Understand that medical paradigms shift slowly. While advocating for yourself and others, acknowledge that widespread adoption of evidence-based hormonal care, especially for women, will take time and persistent effort.